226 related articles for article (PubMed ID: 21105197)
41. Assessment of Laparoscopic Distal Gastrectomy After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Randomized Clinical Trial.
Li Z; Shan F; Ying X; Zhang Y; E JY; Wang Y; Ren H; Su X; Ji J
JAMA Surg; 2019 Dec; 154(12):1093-1101. PubMed ID: 31553463
[TBL] [Abstract][Full Text] [Related]
42. [Survival analysis of gastric cancer cases with pathological complete response received neoadjuvant chemotherapy].
Zhang Y; Peng Z; Chen L
Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1582-4. PubMed ID: 27266687
[TBL] [Abstract][Full Text] [Related]
43. No Difference in Survival between Neo-Adjuvant Chemotherapy and Neo-Adjuvant Chemoradiation Therapy in Gastric Cardia Cancer Patients: A Contemporary View from the National Cancer Database.
Tsai C; Mueller A; Maubach J; Warschkow R; Nussbaum DP; Schmied BM; Blazer D; Gloor B; Worni M
Dig Surg; 2020; 37(3):249-257. PubMed ID: 31340206
[TBL] [Abstract][Full Text] [Related]
44. Prognostic significance of the concomitant existence of lymphovascular and perineural invasion in locally advanced gastric cancer patients who underwent curative gastrectomy and adjuvant chemotherapy.
Hwang JE; Hong JY; Kim JE; Shim HJ; Bae WK; Hwang EC; Jeong O; Park YK; Lee KH; Lee JH; Cho SH; Chung IJ
Jpn J Clin Oncol; 2015 Jun; 45(6):541-6. PubMed ID: 25759484
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and safety of target combined chemotherapy in advanced gastric cancer: a meta-analysis and system review.
Zou K; Yang S; Zheng L; Yang C; Xiong B
BMC Cancer; 2016 Sep; 16(1):737. PubMed ID: 27633381
[TBL] [Abstract][Full Text] [Related]
46. Factors associated with early recurrence after curative surgery for gastric cancer.
Kang WM; Meng QB; Yu JC; Ma ZQ; Li ZT
World J Gastroenterol; 2015 May; 21(19):5934-40. PubMed ID: 26019458
[TBL] [Abstract][Full Text] [Related]
47. The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial.
Wang X; Li S; Sun Y; Li K; Shen X; Xue Y; Liang P; Li G; Chen L; Zhao Q; Li G; Fu W; Liang H; Xin H; Suo J; Fang X; Zheng Z; Xu Z; Chen H; Zhou Y; He Y; Huang H; Zhu L; Yang K; Ji J; Ye Y; Zhang Z; Li F; Wang X; Tian Y; Park S; Chen L
BMC Cancer; 2021 Jan; 21(1):20. PubMed ID: 33402102
[TBL] [Abstract][Full Text] [Related]
48. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
49. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
Lu W; Zeng X; Li N; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
[TBL] [Abstract][Full Text] [Related]
50. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
[TBL] [Abstract][Full Text] [Related]
51. Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.
Barone C; Cassano A; Pozzo C; D'Ugo D; Schinzari G; Persiani R; Basso M; Brunetti IM; Longo R; Picciocchi A
Oncology; 2004; 67(1):48-53. PubMed ID: 15459495
[TBL] [Abstract][Full Text] [Related]
52. [Neoadjuvant chemotherapy for locally advanced gastric cancer].
Kalmár K; Cseke L; Káposztás Z; Horváth G; Varga E
Magy Seb; 2003 Oct; 56(5):177-84. PubMed ID: 15022621
[TBL] [Abstract][Full Text] [Related]
53. Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis.
Miao ZF; Liu XY; Wang ZN; Zhao TT; Xu YY; Song YX; Huang JY; Xu H; Xu HM
BMC Cancer; 2018 Jan; 18(1):118. PubMed ID: 29385994
[TBL] [Abstract][Full Text] [Related]
54. Impact of ypT, ypN, and Adjuvant Therapy on Survival in Gastric Cancer Patients Treated with Perioperative Chemotherapy and Radical Surgery.
Coimbra FJF; de Jesus VHF; Ribeiro HSC; Diniz AL; de Godoy AL; de Farias IC; Felismino T; Mello CAL; Almeida MF; Begnami MDFS; Dias-Neto E; Riechelmann RSP; da Costa WL
Ann Surg Oncol; 2019 Oct; 26(11):3618-3626. PubMed ID: 31222685
[TBL] [Abstract][Full Text] [Related]
55. [Meta-analysis of adjuvant chemotherapy on prognosis for gastric cancer patients after D2 dissection].
Xia GG; Zhang CH; Wei ZW; Wu Y; He YL
Zhonghua Wai Ke Za Zhi; 2013 May; 51(5):447-51. PubMed ID: 23958170
[TBL] [Abstract][Full Text] [Related]
56. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
[TBL] [Abstract][Full Text] [Related]
57. Pathological response measured using virtual microscopic slides for gastric cancer patients who underwent neoadjuvant chemotherapy.
Kawai S; Shimoda T; Nakajima T; Terashima M; Omae K; Machida N; Yasui H
World J Gastroenterol; 2019 Sep; 25(35):5334-5343. PubMed ID: 31558877
[TBL] [Abstract][Full Text] [Related]
58. A systematic overview of chemotherapy effects in gastric cancer.
Janunger KG; Hafström L; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):309-26. PubMed ID: 11441938
[TBL] [Abstract][Full Text] [Related]
59. Neoadjuvant chemotherapy for gastric cancer: a meta-analysis of randomized, controlled trials.
Liao Y; Yang ZL; Peng JS; Xiang J; Wang JP
J Gastroenterol Hepatol; 2013 May; 28(5):777-82. PubMed ID: 23425049
[TBL] [Abstract][Full Text] [Related]
60. An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer.
Liu TS; Wang Y; Chen SY; Sun YH
Eur J Surg Oncol; 2008 Nov; 34(11):1208-16. PubMed ID: 18353606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
